| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/28/2008 | CN101188941A Method and composition for treating diabetes |
| 05/28/2008 | CN101186922A Gene immunity preparation method for human I-type deoxythymidine kinase monoclonal antibody |
| 05/28/2008 | CN101186918A Corn event PV-IMGT32(NK603) and compositions and methods for detection thereof |
| 05/28/2008 | CN101186901A Method for inducing differentiation of human embryo mesenchymal stem cells into pancreatic islet beta-like cell |
| 05/28/2008 | CN101186900A Process for producing retinal neurocyte and retinal neurocyte produced by the process |
| 05/28/2008 | CN101186899A Method applied for tumour cell and stem cell co-culture |
| 05/28/2008 | CN101186649A Human resource monoclonal antibody for anti-human P-selectin- epidermal growth factor functional region and hybridoma cell strain thereof |
| 05/28/2008 | CN101186641A Anti-arsenic correlated protein, coding gene and application thereof |
| 05/28/2008 | CN101185421A Method of í«hanfuí» apple anther culture plant strain |
| 05/28/2008 | CN100390292C Adenovirus vector specific for cells expressing alpha fetoprotein and methods of use thereof |
| 05/28/2008 | CN100390291C Conditionally replicating viral vectors and their use |
| 05/28/2008 | CN100390290C Method for gene introduction into target cells by retrovirus |
| 05/28/2008 | CN100390289C Method for producing influenza hemagglutinin multivalent vaccines |
| 05/28/2008 | CN100390288C Multivalent antibodies and uses therefor |
| 05/28/2008 | CN100390286C Novel enzyme gene and its expression product |
| 05/28/2008 | CN100390275C High fidelity reverse transcriptases and uses thereof |
| 05/28/2008 | CN100390274C Method and application of betle extract inducing IFN gamma from human peripheral blood monocyte, and application thereof |
| 05/28/2008 | CN100390273C Culture medium for inducing garlic somatic embryo |
| 05/28/2008 | CN100390264C A device. |
| 05/28/2008 | CN100390195C Modulators of function of FAS receptors and other proteins |
| 05/28/2008 | CN100389650C Method for building regenerative system of kostelezkya virginica |
| 05/27/2008 | US7379766 CMOS-process compatible high-DC surface coating for capacitive detection and stimulation of biological tissues |
| 05/27/2008 | US7378580 Inbred corn line G06-NP2546 |
| 05/27/2008 | US7378579 Corn inbred 3B50HO |
| 05/27/2008 | US7378574 Soybean variety XB07N06 |
| 05/27/2008 | US7378569 Transgenic pigs carrying both hHO-1 and hDAF transgenes for xenotransplantation |
| 05/27/2008 | US7378515 Synthetic gagpol genes and their uses |
| 05/27/2008 | US7378513 Isolated proteins from a traditional Chinese medicine Yuzhu and use thereof |
| 05/27/2008 | US7378511 Comprises nucleotide sequences coding aspartyl protease for identifying modulators for treatment of nervous system disorders; enzyme inhibitors |
| 05/27/2008 | US7378507 for pharmaceuticals, diagnostics, biosensors and bioreactors; thrombolytic agents, interferons, interleukins, erythropoietins, colony stimulating factors, and cytokines; solid phase synthesis |
| 05/27/2008 | US7378506 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins |
| 05/27/2008 | US7378503 inhibit binding of IGF-1 and IGF-II to IGF-IR so they act as antitumor by reducing tumor growth and/or prolonging the time of tumor progression; hybridoma cell lines; methods of preparing the compositions |
| 05/27/2008 | US7378502 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis |
| 05/27/2008 | US7378493 Expression vector comprising nucleotide sequences coding insecticidal proteins for use in transformation and propagation of insect resistant crop plants; biological pest control |
| 05/27/2008 | US7378488 for promoting the release of growth hormone and of enhancing wound healing in a human or animal subject; for treating short stature, cachexia, wasting, type 2 diabetes, and poor circulation |
| 05/27/2008 | US7378487 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of cell proliferative and tumor disorders |
| 05/27/2008 | US7378445 Treatment of prostate cancer |
| 05/27/2008 | US7378393 Recombinant anticoagulant proteins |
| 05/27/2008 | US7378384 X-Y-Thr-Trp-Asn-Gln-Met-Asn-Leu wherein X represents Ser, Ala, Abu, Arg, Lys, Orn, Cit, Leu, Phe, or Asn, and Y represents Tyr or Met; cysteine residue is substituted with a defined amino acid residue; cancer vaccines |
| 05/27/2008 | US7378278 Enzymes involved in triterpene synthesis |
| 05/27/2008 | US7378277 Transducing a hemopoietic stem cell with nucleic acid; and cellular differentiation into a dendritic cell; genetic engineering; making recombinant antigen presenting dendritic cells |
| 05/27/2008 | US7378276 Method of inducing memory B cell development and terminal differentiation |
| 05/27/2008 | US7378274 Regulatory nucleic acid for the ABC1 gene, molecules modifying its activity and therapeutic uses |
| 05/27/2008 | US7378273 Plasmid construct comprising hybrid alpha -lactalbumin promoter for use as gene transfer and expression tool in genetic engineering; gene therapy and tissue engineering |
| 05/27/2008 | US7378272 Mosquito cell culture for propagation of sindbis viral vectors; genetic engineering and vehicles for gene transfer |
| 05/27/2008 | US7378261 using an enzyme of given amino acid sequence having para-hydroxycinnamic acid decarboxylase activity; solvent extraction, high yield; also biosynthesis of derivatives such as para-acetoxystyrene |
| 05/27/2008 | US7378252 Signal transduction |
| 05/27/2008 | US7378096 biodrugs comprising heat shock protein or glucose-regulated proteins complexed with immuogens including glycoproteins, her2/neu proteins or tuberculosis antigens, and carriers, used as anticarcinogenic agents |
| 05/27/2008 | US7378089 Supplying suppressive genetic engineered cells; antiinflammatory agents |
| 05/27/2008 | US7378087 Method of enhancing an immune response |
| 05/27/2008 | US7378078 Chimeric polypeptide comprising bioluminescent/chemiluminescent, kinase and/or silencing domains for monitoring efficacy of therapeutic agents |
| 05/27/2008 | US7377027 Container uncapping mechanism |
| 05/27/2008 | CA2275974C Methods for producing parthenocarpic or female sterile transgenic plants |
| 05/27/2008 | CA2180786C Plants containing the gdha gene and methods of use thereof |
| 05/27/2008 | CA2145641C Pseudo-adenovirus vectors |
| 05/27/2008 | CA2120358C Hormone analogs with multiple ctp extensions |
| 05/27/2008 | CA2117181C Induction of cytolytic t-lymphocytes with cytomegalovirus polypeptides |
| 05/22/2008 | WO2008061148A2 Methods and compositions for cryopreserving oocytes |
| 05/22/2008 | WO2008060813A2 High affinity antibody antagonists of interleukin-13 receptor alpha 1 |
| 05/22/2008 | WO2008060792A2 Novel cells, compositions, and methods |
| 05/22/2008 | WO2008060613A1 Methods and compositions for reducing amyloid beta levels |
| 05/22/2008 | WO2008060541A2 In vitro expansion of postpartum-derived cells using microcarriers |
| 05/22/2008 | WO2008060540A2 Methods of identifying compositions that modulate the protein tyrosine phosphatase, ptp-bl |
| 05/22/2008 | WO2008060240A1 Methods for screening and treatment involving the genes gypc, agpat3, agl, pvrl2, hmgb 3, hsdl2 and/or ldb2 |
| 05/22/2008 | WO2008060156A1 Methods for controlling mineralization of extracellular matrix, therapeutic methods based thereon and medicaments for use therein |
| 05/22/2008 | WO2008060139A1 Methods for controlling mineralization of extracellular matrix, therapeutic methods based thereon and medicaments for use therein |
| 05/22/2008 | WO2008060037A1 Method for the simultaneous primary-isolation and expansion of endothelial stem/progenitor cell and mesenchymal stem cell derived from mammal including human umbilical cord |
| 05/22/2008 | WO2008059917A1 Thrombin mutant |
| 05/22/2008 | WO2008059900A1 Method for screening allergic disease-related molecule and cell line to be used in the method |
| 05/22/2008 | WO2008059837A1 Antibody against aflatoxins, support using the antibody, method of immunologically detecting aflatoxins and method of concentrating and purifying aflatoxins |
| 05/22/2008 | WO2008059777A1 Modified flavine-adenine-dinucleotide-dependent glucose dehydrogenase |
| 05/22/2008 | WO2008059616A1 Antibody recognizing c-domain of midkine |
| 05/22/2008 | WO2008058728A1 Compositions and methods for immunotherapy |
| 05/22/2008 | WO2008058381A1 Cancerous disease modifying antibodies |
| 05/22/2008 | WO2008058380A1 Cancerous disease modifying antibodies |
| 05/22/2008 | WO2008058379A1 Cancerous disease modifying antibodies |
| 05/22/2008 | WO2008033032A3 Method and device for micropropagation of plants |
| 05/22/2008 | WO2007115336A3 A shape-based approach for scaffoldless tissue engineering |
| 05/22/2008 | WO2007050314A3 Medical device with living cell sheet |
| 05/22/2008 | WO2006130320A3 Repair of the bone marrow vasculature |
| 05/22/2008 | WO2006124412A3 Methods for the rapid expansion of antigen specific t-cells |
| 05/22/2008 | US20080120750 Promoters for regulation of plant expression |
| 05/22/2008 | US20080120740 Novel Nucleic Acid Sequences and Their Use in Methods for Achieving a Pathogenic Resistance in Plants |
| 05/22/2008 | US20080120739 Using auxin-like herbicide as slective agent in identifying transformed plant cells |
| 05/22/2008 | US20080120738 Expression vector comprising fusion sequences coding terminal region of photosystem A gene and cellulase for use in transformation of plastids; bioconversion of cellulose to ethanol |
| 05/22/2008 | US20080120734 Compositions and methods for regulated protein expression in gut |
| 05/22/2008 | US20080120733 Using RNA interference and reduction in hypoxanthine phosphoribosyltransferase expression as reporter signal to identify transgenic cells |
| 05/22/2008 | US20080120732 Method for Improved Transgene Expression |
| 05/22/2008 | US20080120731 Rodent model demonstrating anterior pharynx defective phenotype (APH) for use as tool in identifying secretase modulators for prevention and treatment of neurodegenerative diseases |
| 05/22/2008 | US20080119685 Methods for modulating checkpoint activation through TopBP1 |
| 05/22/2008 | US20080119638 Human endothelin receptor |
| 05/22/2008 | US20080119571 Transport proteins; lecithin-cholesterol acyltransferase; for increasing circulating high density lipoprotein cholesterol for treating atherosclerosis and related cardiovascular disorders |
| 05/22/2008 | US20080119566 Sedatives; oxidation resistance; nervous system disorders |
| 05/22/2008 | US20080119555 Aryl Alkyl Sulfonamides As Therapeutic Agents For The Treatment Of Bone Conditions |
| 05/22/2008 | US20080119541 Novel genes encoding a nystatin polyketide synthase and their manipulation and utility |
| 05/22/2008 | US20080119532 2-Methylamino-N-{2-(6-{1-methyl-2-(2-methylamino-propionylamino)-3-oxo-3-[2-(5-phenoxy-tetrazol-1-ylmethyl)-pyrrolidine-1-yl]-propoxy}-hexa-2,4-diynyloxy)-1-[2-(5-phenoxy-tetrazol-1-ylmethyl)-pyrrolidine-1-carbonyl]-propyl}-propionamide; mimetics of second mitochondria-derived activator of caspases |
| 05/22/2008 | US20080119488 Modulators Of Nuclear Receptors |
| 05/22/2008 | US20080119453 Bicyclic derivatives as modulators of ion channels |
| 05/22/2008 | US20080119447 6-alkoxyalkyl estradiol derivatives and methods of use |
| 05/22/2008 | US20080119435 Hes6 as a marker of pancreatic endocrine cells |